Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients.
Sifontis
N M
NM
Department of Pharmacy Practice, University of Illinois at Chicago, 833 S. Wood Street, Chicago, IL 60612, USA.
Benedetti
E
E
Vasquez
E M
EM
D000911:Antibodies, Monoclonal / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077552:Basiliximab; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008499:Medical Records; D008657:Metabolic Clearance Rate; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D016559:Tacrolimus; D008775:Methylprednisolone